MicroRNA-488 serves as a diagnostic marker for atherosclerosis and regulates the biological behavior of vascular smooth muscle cells

References

• Frostegård J. Immunity, atherosclerosis and cardiovascular disease. BMC Med. 2013 May 1;11:117.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Xian X, Wang Z, et al. Research progress on the relationship between atherosclerosis and inflammation. Biomolecules. 2018 Aug 23;8(3):80.
   Web of Science ®Google Scholar
• Xu H, Jiang J, Chen W, et al. Vascular macrophages in atherosclerosis. J Immunol Res. 2019;2019:4354786.
   PubMed Web of Science ®Google Scholar
• Balogh E, Pusztai A, Hamar A, et al. Autoimmune and angiogenic biomarkers in autoimmune atherosclerosis. Clin Immunol. 2019 Feb;199:47–51.
   PubMed Web of Science ®Google Scholar
• Li B, Li W, Li X, et al. Inflammation: a novel therapeutic target/direction in atherosclerosis. Curr Pharm Des. 2017;23(8):1216–1227.
   PubMed Web of Science ®Google Scholar
• Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev. 2006 Apr;86(2):515–581.
   PubMed Web of Science ®Google Scholar
• Luo Y, Lu S, Gao Y, et al. Araloside C attenuates atherosclerosis by modulating macrophage polarization via Sirt1-mediated autophagy. Aging (Albany NY). 2020 Jan 27;12(2):1704–1724.
   PubMedGoogle Scholar
• Foks AC, Bot I. Preface: pathology and pharmacology of atherosclerosis. Eur J Pharmacol. 2017 Dec 5;816:1–2.
   PubMed Web of Science ®Google Scholar
• Tibaut M, Caprnda M, Kubatka P, et al. Markers of atherosclerosis: part 2 - genetic and imaging markers. Heart Lung Circ. 2019 May;28(5):678–689.
   PubMed Web of Science ®Google Scholar
• Correia de Sousa M, Gjorgjieva M, Dolicka D, et al. Deciphering miRNAs’ action through miRNA editing. Int J Mol Sci. 2019 Dec 11;20(24):6249.
   PubMed Web of Science ®Google Scholar
• Tiwari A, Mukherjee B, Dixit M. MicroRNA key to angiogenesis regulation: miRNA biology and therapy. Curr Cancer Drug Targets. 2018;18(3):266–277.
   PubMed Web of Science ®Google Scholar
• Bernardo BC, Ooi JY, Lin RC, et al. miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart. Future Med Chem. 2015;7(13):1771–1792.
   PubMed Web of Science ®Google Scholar
• Ferdin J, Kunej T, Calin GA. Non-coding RNAs: identification of cancer-associated microRNAs by gene profiling. Technol Cancer Res Treat. 2010 Apr;9(2):123–138.
   PubMed Web of Science ®Google Scholar
• Feinberg MW, Moore KJ. MicroRNA regulation of atherosclerosis. Circ Res. 2016 Feb 19;118(4):703–720.
   PubMed Web of Science ®Google Scholar
• Lu Y, Thavarajah T, Gu W, et al. Impact of miRNA in Atherosclerosis. Arterioscler Thromb Vasc Biol. 2018 Sep;38(9):e159–e170.
   PubMed Web of Science ®Google Scholar
• Liang J, Zhang Z. Higher peripheral blood MiR-488 level predicts poor prognosis of acute ischemic stroke. Clin Lab. 2020 Jul 1;66(7). DOI:10.7754/Clin.Lab.2020.191230.
   Web of Science ®Google Scholar
• Lv H, Hou H, Lei H, et al. MicroRNA-6884-5p regulates the proliferation, invasion, and EMT of gastric cancer cells by directly targeting S100A16. Oncol Res. 2020 May 29;28(3):225–236.
   PubMed Web of Science ®Google Scholar
• Chen L, Zhu Q, Lu L, et al. MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1. Bioengineered. 2020 Dec;11(1):91–102.
   Google Scholar
• Wang S, Li P, Jiang G, et al. Long non-coding RNA LOC285194 inhibits proliferation and migration but promoted apoptosis in vascular smooth muscle cells via targeting miR-211/PUMA and TGF-β1/S100A4 signal. Bioengineered. 2020 Dec;11(1):718–728.
   Google Scholar
• Mozos I, Borzak G, Caraba A, et al. Arterial stiffness in hematologic malignancies. Onco Targets Ther. 2017;10:1381–1388.
   PubMed Web of Science ®Google Scholar
• Papanagnou P, Stivarou T, Papageorgiou I, et al. Marketed drugs used for the management of hypercholesterolemia as anticancer armament. Onco Targets Ther. 2017;10:4393–4411.
   PubMed Web of Science ®Google Scholar
• Tímár J, Döme B, Fazekas K, et al. Angiogenesis-dependent diseases and angiogenesis therapy. Pathol Oncol Res. 2001;7(2):85–94.
   PubMedGoogle Scholar
• Libby P, Bornfeldt KE, Tall AR. Atherosclerosis: successes, surprises, and future challenges. Circ Res. 2016 Feb 19;118(4):531–534.
   PubMed Web of Science ®Google Scholar
• Nezu T, Hosomi N, Aoki S, et al. Carotid intima-media thickness for atherosclerosis. J Atheroscler Thromb. 2016;23(1):18–31.
   PubMed Web of Science ®Google Scholar
• Yan W, Yang W, Liu Z, et al. Characterization of microRNA expression in primary human colon adenocarcinoma cells (SW480) and their lymph node metastatic derivatives (SW620). Onco Targets Ther. 2018;11:4701–4709.
   PubMed Web of Science ®Google Scholar
• Laffont B, Rayner KJ. MicroRNAs in the pathobiology and therapy of atherosclerosis. Can J Cardiol. 2017 Mar;33(3):313–324.
   PubMed Web of Science ®Google Scholar
• Ding S, Huang H, Xu Y, et al. MiR-222 in cardiovascular diseases: physiology and pathology. Biomed Res Int. 2017;2017:4962426.
   PubMed Web of Science ®Google Scholar
• Zhang X, Dong S, Jia Q, et al. The microRNA in ventricular remodeling: the miR-30 family. Biosci Rep. 2019 Aug 30;39(8):BSR20190788.
   Google Scholar
• Zheng B, Yin WN, Suzuki T, et al. Exosome-mediated miR-155 transfer from smooth muscle cells to endothelial cells induces endothelial injury and promotes atherosclerosis. Mol Ther. 2017 Jun 7;25(6):1279–1294.
   PubMed Web of Science ®Google Scholar
• Xu Y, Xu Y, Zhu Y, et al. Macrophage miR-34a is a key regulator of cholesterol efflux and atherosclerosis. Mol Ther. 2020 Jan 8;28(1):202–216.
   PubMed Web of Science ®Google Scholar
• Han D, Zhang X, Zhang J, et al. Oleanolic acid suppresses vascular smooth muscle cell proliferation by increasing lincRNA-p21 expression. Oncol Lett. 2016 Nov;12(5):3519–3522.
   PubMed Web of Science ®Google Scholar
• Li FP, Lin DQ, Gao LY. LncRNA TUG1 promotes proliferation of vascular smooth muscle cell and atherosclerosis through regulating miRNA-21/PTEN axis. Eur Rev Med Pharmacol Sci. 2018 Nov;22(21):7439–7447.
   PubMed Web of Science ®Google Scholar
• Zhuang X, Gao F, Shi L, et al. MicroRNA-146b-3p regulates the dysfunction of vascular smooth muscle cells via repressing phosphoinositide-3 kinase catalytic subunit gamma. Bioengineered. 2021 Dec;12(1):2627–2638.
   Google Scholar